Evidence map›Paper›PMID 25335168›Full record

ArticleTranslational psychiatry2014

Common variants at 1p36 are associated with superior frontal gyrus volume.

R Hashimoto, M Ikeda, F Yamashita, K Ohi, H Yamamori, Y Yasuda, M Fujimoto, M Fukunaga, K Nemoto, T Takahashi and 10 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Calpain-14 and its association with eosinophilic esophagitis.The Journal of allergy and clinical immunology · 2017
    Review
  10. Article
  11. Article
  12. Imaging genetics and psychiatric disorders.Current molecular medicine · 2015
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 1 country.

R Hashimoto1] Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Suita, Osaka, Japan [2] Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
M IkedaDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
F YamashitaDivision of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University, Yahaba, Iwate, Japan.
K OhiDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
H Yamamori1] Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Osaka, Japan [2] Department of Molecular Neuropsychiatry, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Y YasudaDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
M FujimotoDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
M FukunagaBiofunctional Imaging, Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
K NemotoDepartment of Neuropsychiatry, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.
T TakahashiDepartment of Neuropsychiatry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
M TochigiDepartment of Neuropsychiatry, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
T OnitsukaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
H YamasueDepartment of Neuropsychiatry, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
K MatsuoDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
T IidakaDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
N IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
M SuzukiDepartment of Neuropsychiatry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
M Takeda1] Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Suita, Osaka, Japan [2] Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
K KasaiDepartment of Neuropsychiatry, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
N OzakiDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Osaka University · JPThe University of Tokyo · JPFujita Health University · JPNagoya University · JPUniversity of Toyama · JPIwate Medical University · JPKyushu University · JPUniversity of Tsukuba · JPYamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The superior frontal gyrus (SFG), an area of the brain frequently found to have reduced gray matter in patients with schizophrenia, is involved in self-awareness and emotion, which are impaired in schizophrenia. However, no genome-wide association studies of SFG volume have investigated in patients with schizophrenia. To identify single-nucleotide polymorphisms (SNPs) associated with SFG volumes, we demonstrated a genome-wide association study (GWAS) of gray matter volumes in the right or left SFG of 158 patients with schizophrenia and 378 healthy subjects. We attempted to bioinformatically ascertain the potential effects of the top hit polymorphism on the expression levels of genes at the genome-wide region. We found associations between five variants on 1p36.12 and the right SFG volume at a widely used benchmark for genome-wide significance (P<5.0 × 10(-8)). The strongest association was observed at rs4654899, an intronic SNP in the eukaryotic translation initiation factor 4 gamma, 3 (EIF4G3) gene on 1p36.12 (P=7.5 × 10(-9)). No SNP with genome-wide significance was found in the volume of the left SFG (P>5.0 × 10(-8)); however, the rs4654899 polymorphism was identified as the locus with the second strongest association with the volume of the left SFG (P=1.5 × 10(-6)). In silico analyses revealed a proxy SNP of rs4654899 had effect on gene expression of two genes, HP1BP3 lying 3' to EIF4G3 (P=7.8 × 10(-6)) and CAPN14 at 2p (P=6.3 × 10(-6)), which are expressed in moderate-to-high levels throughout the adult human SFG. These results contribute to understand genetic architecture of a brain structure possibly linked to the pathophysiology of schizophrenia.

Indexed as

AdultBrain MappingComputational BiologyFemaleFrontal LobeGene ExpressionGenome-Wide Association StudyGray MatterHumansMagnetic Resonance ImagingMalePolymorphism, Single NucleotideSchizophrenia

Identifiers

PMID25335168
PMCPMC4350516
OpenAlexW2078783172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.